CLINICAL_TRIALS
trial_result
· 2021-06-14
Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy, safety, and tolerability of JTE-051 in active rheumatoid arthritis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akros Pharma Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-14